ALLO - Volume dana dhuwit perusahaan Allogene Therapeutics Inc

Lambang korporat lan logo allogene.com (ALLO)

The cash position on the GURU.Markets chart demonstrates Allogene Therapeutics (ALLO) diversified approach to developing CAR-T therapies against various tumors, while the 0.30 metric reflects current dynamics. Strong clinical interest in off-the-shelf blood cancer treatments is driving demand. Meanwhile, the business's financial stability relies on research results, remaining independent of market cycles.

Allogene Corp - Sisa dhuwit perusahaan ALLO (periode 04.07.2022 - 21.11.2026)

Rincian metrik keuangan lan pasar Allogene (ALLO)

- nilai saham lan prakiraan konsensus rega:
Analisis kabeh metrik perusahaan:ALLO Allogene Therapeutics
Produk merek allogene.com

This indicator measures the volume of highly liquid assets, determining the business's ability to cover operating expenses and invest in growth without incurring external debt. For Allogene Therapeutics (ALLO), this reserve is critical when scaling the production of finished CAR-T therapies. By analyzing the company's cash history, an investor assesses the burn rate during the technology patenting period. A stable liquidity balance confirms the resilience of the business model and enhances its investment potential.